• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Harmony Starts First-In-Human Study Of Orexin 2 Agonist BP1.15205

    BUSINESSWIRE

    Alkermes Pushes Narcolepsy Program to Phase 3 With Mid-Stage Data

    BIOSPACE

    Takeda, Alkermes Reveal Narcolepsy Rivals Amid Intensifying Race

    FIERCE BIOTECH

    Takeda To Present Additional Data On TAK-861 For Narcolepsy

    BUSINESSWIRE

    Nxera`s Partner Centessa Reports Positive Data For Novel Orexin Agonist

    GLOBENEWSWIRE

    Centessa Reports Positive ORX750 Phase 1 Interim Data

    GLOBENEWSWIRE

    Takeda`s TAK-861 Shows Narcolepsy Type 1 Benefit Vs Placebo

    BUSINESSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.